Literature DB >> 3290683

Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide.

K Arahata1, S Ishiura, T Ishiguro, T Tsukahara, Y Suhara, C Eguchi, T Ishihara, I Nonaka, E Ozawa, H Sugita.   

Abstract

Duchenne muscular dystrophy (DMD) is a debilitating X-linked muscle disease. We have used sequence information from complementary DNA clones, derived from the gene that is deleted in DMD patients, to generate an antiserum that stains the surface membrane of intact human and mouse skeletal muscle, but not that of DMD patients and mdx mice. Here we identify the protein reacting with this antiserum as a single component of relative molecular mass 210,000 (Mr = 210K) that fractionates with a low-ionic strength extract of intact human and mouse skeletal muscle. It is therefore distinct from the 400 K protein found in the heavy microsomal fraction of normal muscle and identified as a putative product of the DMD gene. We also analyse further the disease specificity of the antiserum. Positive staining is seen in normal controls, and in samples from patients with a wide range of muscular dystrophies other than DMD. Becker muscular dystrophy, which is allelically related to DMD, was the only other exception, and gave a sporadic staining pattern. The demonstration of a specific defect in the surface membrane of DMD muscle fibres substantiates the hypothesis that membrane lesions may initiate muscle degradation in DMD.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3290683     DOI: 10.1038/333861a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  119 in total

1.  Dystrophin-associated proteins in obliquely striated muscle of the leech Pontobdella muricata (Annelida, Hirudinea).

Authors:  M Royuela; G Hugon; F Rivier; R Paniagua; D Mornet
Journal:  Histochem J       Date:  2001-03

2.  "Quadriceps myopathy": a clinical variant form of Becker muscular dystrophy.

Authors:  Y Wada; Y Itoh; T Furukawa; H Tsukagoshi; K Arahata
Journal:  J Neurol       Date:  1990-08       Impact factor: 4.849

3.  Isolated dystrophin molecules as seen by electron microscopy.

Authors:  F Pons; N Augier; R Heilig; J Léger; D Mornet; J J Léger
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

Review 4.  The muscular dystrophies.

Authors:  V Dubowitz
Journal:  Postgrad Med J       Date:  1992-07       Impact factor: 2.401

5.  2004 William Allan Award address. Cloning of the DMD gene.

Authors:  Louis M Kunkel
Journal:  Am J Hum Genet       Date:  2005-02       Impact factor: 11.025

6.  Myocardial dystrophin immunolocalization at sarcolemma and transverse tubules.

Authors:  R Yarom; G E Morris; R Froede; J Schaper
Journal:  Experientia       Date:  1992-06-15

7.  An intact cysteine-rich domain is required for dystrophin function.

Authors:  R D Bies; C T Caskey; R Fenwick
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

Review 8.  Diagnosis and cell-based therapy for Duchenne muscular dystrophy in humans, mice, and zebrafish.

Authors:  Louis M Kunkel; Estanislao Bachrach; Richard R Bennett; Jeffrey Guyon; Leta Steffen
Journal:  J Hum Genet       Date:  2006-04-01       Impact factor: 3.172

9.  Dystrophin deficiency is associated with myotendinous junction defects in prenecrotic and fully regenerated skeletal muscle.

Authors:  D J Law; J G Tidball
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

10.  Immunohistochemical study of calpain and its endogenous inhibitor in the skeletal muscle of muscular dystrophy.

Authors:  T Kumamoto; H Ueyama; S Watanabe; K Yoshioka; T Miike; D E Goll; M Ando; T Tsuda
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.